Hoya Group Reports Significant Increases in Sales and Profits in First Quarter

By Staff
Friday, July 30, 2021 12:27 AM TOKYO—Boosted by strong sales in both North America and Europe, Hoya Group (7741:JP) on Thursday reported that sales for the first quarter (April 1 through June 30) of its current fiscal year totaled 158,000 million yen, an increase of 44.5 percent from the same period of the previous fiscal year. The quarterly profit before tax totaled 51,018 million yen, and quarterly profit amounted to 41,299 million yen, up 59.7 percent and 61.1 percent, respectively. The quarterly profit margin before tax was 32.3 percent, representing a year-on-year increase of 3.1 points.

Kering Reports 'Strong Momentum' in Eyewear in First Fiscal Half

By Staff
Wednesday, July 28, 2021 12:21 AM PARIS—As it released its financial performance for the first fiscal half of the year, Kering Group (PARIS: KER), the luxury conglomerate, cited  the "strong momentum of Kering Eyewear, with sales up 61.8 percent on a comparable basis."

Bausch + Lomb to Invest €90 Million in Waterford, Ireland, Facility to Expand Capacity for Biotrue ONEday Lenses

By Staff
Friday, July 23, 2021 12:18 AM WATERFORD, Ireland—Bausch + Lomb this week announced plans to invest €90 million to expand manufacturing operations at its Waterford facility in Ireland. The investment is expected to generate 130 additional jobs when production commences in 2023 and will provide the Waterford facility with additional capacity to meet expected demand for its Biotrue ONEday range of contact lenses, B+L said in the announcement. The investment will further strengthen the Waterford plant’s position in supporting Bausch + Lomb’s efforts to increase market share in the contact lens market.

Johnson & Johnson Reports Rebound in Sales and Earnings, With Vision Care Segment Also Bouncing Back from 2020’s Dropoff

By Staff
Thursday, July 22, 2021 12:24 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) reported Wednesday that its second-quarter sales increased 27.1 percent to $23.3 billion, with operational sales growth of 23 percent and adjusted operational growth of 23.8 percent. Net earnings increased 73.1 percent, totaling $6.3 billion in the recent quarter compared with $3.6 billion in the year-ago period, according to the announcement.

Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-Cleared AI Technology for Detection of Diabetic Retinopathy

By Staff
Wednesday, July 21, 2021 12:24 AM LOS ANGELES—Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and a leader in real-world applications for AI Eye Screening, announced Tuesday that it has completed a financing round of $6.2 million led by AXA IM.

U.S. Leads in Crypto ATMs

By Staff
Monday, July 19, 2021 11:00 AM The U.S. is the world's most "crypto-ready" country, according to a recently released ranking by crypto education platform Crypto Head. As Statista data journalist Niall McCarthy observed in a blog post last week, the research delved into several factors impacting cryptocurrencies around the world such as public interest, the government's legal stance as well as ownership of digital currency. A further important element was the accessibility of Bitcoin, Dogecoin and co, especially the prevalence of crypto ATMs.

Sight Sciences Announces Pricing of Initial Public Offering

By Staff
Friday, July 16, 2021 12:30 AM MENLO PARK, Calif.—Sight Sciences Inc., a growth-stage medical device company working to develop and commercialize devices that target the underlying causes of some prevalent eye diseases, priced its initial public offering of 10 million shares of common stock at a price of $24 per share.

Binovi Announces Board and Management Changes as Company Shifts from ‘Technology Development to Commercial Growth’

By Staff
Wednesday, July 14, 2021 12:21 AM TORONTO and NEW YORK—Binovi Technologies Corp. (TSX-V:VISN) announced Tuesday that Tania Archer has been appointed as interim CEO of the company, succeeding Adam Cegielski, who stepped down from his positions as CEO and board member.

Eyemart Express Names Mike Loftus to Chief Financial Officer Post

By Staff
Wednesday, July 14, 2021 12:18 AM DALLAS—Eyemart Express, a national optical retailer with more than 200 locations, has announced that Mike Loftus will join the company as chief financial officer, effective July 20.

Nicox to Get $2 Million from Ocumension Therapeutics Under Zerviate Agreement

By Staff
Monday, July 12, 2021 12:15 AM SOPHIA ANTIPOLIS, France—Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, announced July 5 that it has amended its March 2019 license agreement with Ocumension Therapeutics, under which Ocumension has exclusive rights to develop and commercialize Zerviate (cetirizine ophthalmic solution), 0.24% in the Chinese and the majority of South East Asian markets. Under the amended agreement, Ocumension will immediately pay Nicox $2 million in full advance payment of the future development and regulatory milestones for the product. Amendments were made to certain rights under non-financial clauses of the agreement.

The Vision Council’s Latest VisionWatch Report Shows Rise in Consumer Purchasing in Q1

By Staff
Friday, July 9, 2021 12:27 AM ALEXANDRIA, Va.—The Vision Council has released its quarterly VisionWatch market research reports for Q1 of 2021, indicating that the U.S. vision correction industry generated $11.58 billion in sales revenue during the first quarter of 2021, representing an increase of 16.5 percent from Q1 2020 levels and an increase of 1.9 percent from Q1 2019 levels.  Additionally, total vision correction usage rose by 0.4 percent, an equivalent of 196.8 million adults, during the year-ending period March 2021.

RegeneRx Biopharmaceuticals Closes $2 Million Private Placement

By Staff
Wednesday, July 7, 2021 12:15 AM ROCKVILLE, Md.—RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced July 1 that it closed its previously announced private placement offering of common stock and warrants for gross proceeds of $1,980,000.

EssilorLuxottica Acquires HAL's 76.72 Percent Interest in GrandVision and Announces Mandatory Public Offer for Remaining GrandVision Shares

By Staff
Thursday, July 1, 2021 12:43 PM EssilorLuxottica acquires HAL’s interest in GrandVision, NECO and Warby expand scholarship program, optical sales show some improvement, Jobson Tracker says, Zeiss welcomes ECPs to new showroom and VM issues its Top 50 Retailers report all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

EssilorLuxottica Acquires HAL's 76.72 Percent Interest in GrandVision and Announces Mandatory Public Offer for Remaining GrandVision Shares

By Staff
Thursday, July 1, 2021 12:40 PM CHARENTON-LE-PONT, France—EssilorLuxottica (Euronext: EL) announced today that it has completed its acquisition of a 76.72 percent ownership interest in GrandVision from HAL Optical Investments, a wholly-owned subsidiary of HAL Holding, pursuant to the block trade agreement entered into with HAL on July 30, 2019. As a result of the completion of the transaction contemplated by the block trade agreement, EssilorLuxottica acquired “predominant control over GrandVision and is under an obligation to launch a mandatory public offer for all outstanding shares in GrandVision, in accordance with the applicable Dutch public offer rules.

EssilorLuxottica Announces Decision to Close the Acquisition of GrandVision on July 1, in Accordance With Terms and Conditions of the Agreements Signed July 2019

By Staff
Tuesday, June 29, 2021 1:13 PM



CHARENTON-LE-PONT, France—Following the approval by its board of directors, EssilorLuxottica (Euronext: EL) today announced its decision to complete the acquisition of HAL’s 76.72 percent interest in GrandVision (Euronext: GVNV) on July 1, 2021 as per the terms and conditions of the agreement entered into on July 30, 2019. “After assessing all our options, we have made the decision to proceed with the completion of the deal without further delay. The strategic rationale of the transaction remains strong and unchanged, and after two years of efforts and relentless work, we are now ready to turn a page and start a new chapter of EssilorLuxottica’s history, with GrandVision," said Francesco Milleri and Paul du Saillant, respectively CEO and Deputy CEO of EssilorLuxottica.